There are 12 resources available
Welcome and Learning Objectives Introduction
Presenter: S. Peters, CH and T. Powles, UK
Session: Welcome and Introduction
Resources:
Slides
Webcast
ADC Clinical Landscape in Lung Cancer
Presenter: S. Peters, CH
Session: Session 1 – Current Landscape
Resources:
Slides
Webcast
ADC Clinical Landscape in GU Cancers
Presenter: T. Powles, UK
Session: Session 1 – Current Landscape
Resources:
Slides
Webcast
Mechanisms of Action and Resistance: ADC Internalization and Cleavage and Mechanisms of Resistance
Presenter: G. von Amsberg, DE
Session: Session 2 – ADC Development and Pharmacodynamics - Part I
Resources:
Slides
Webcast
ADC Development: What are the Considerations in Early Phase Trials
Presenter: A. Italiano, FR
Session: Session 2 – ADC Development and Pharmacodynamics - Part I
Resources:
Slides
Webcast
Considerations from Pathology: Biomarker Selection, On-Target, Off-Tumour Expression, Off-Target Toxicities
Presenter: L. Bubendorf, CH
Session: Session 3 – Target Assessment and Rationale for Combinations
Resources:
Slides
Webcast
How to Develop Rational Combinations and Sequencing
Presenter: M. van der Heijden, NL
Session: Session 4 – Next Generation ADCs – Part I
Resources:
Slides
Developments in ADC Constructs Including Bispecific ADCs
Presenter: A. Stenzinger, DE
Session: Session 4 – Next Generation ADCs – Part II
Resources:
Slides
Additional Innovative Strategies: Cytokine Conjugates, Peptide-Based Conjugates
Presenter: A. Stenzinger, DE
Session: Session 4 – Next Generation ADCs – Part II
Resources:
Slides
Future Perspectives for Lung Cancer
Presenter: E. Felip, ES
Session: Session 5 – Developments Across Diseases
Resources:
Slides